Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 13/20 | 0.56 |
| ▸ | CA1 | P00915 | 11/20 | 0.56 |
| ▸ | CA9 | Q16790 | 7/20 | 0.56 |
| ▸ | CA12 | O43570 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valeric Acid SCHEMBL29009893 | 0.85 | HTR7 (0.66) | LMNAHSD17B10HTR7TSHR | |
| Benzenesulfonamide SCHEMBL9476757 | 0.81 | CA2 (0.57) | CA2CA1CA9CA12HSD17B10 | |
| Valeric Acid SCHEMBL27728287 | 0.78 | HTR7 (0.56) | HSD17B10SMN1; SMN2HTR7TSHR | |
| Valeric Acid SCHEMBL29009917 | 0.77 | HTR7 (0.56) | LMNAHSD17B10HTR7TSHR | |
| Sulfanilamide SCHEMBL28804990 | 0.76 | CA2 (0.59) | CA2CA1CA9CA12CA4 | |
| SCHEMBL31527705 | 0.75 | SOS1 (0.75) | CA2CA1CA9CA12CA4 | |
| SCHEMBL283919 | 0.75 | SOS1 (0.75) | CA2CA1CA9CA12CA4 | |
| Sulfanilamide SCHEMBL28805038 | 0.74 | CA2 (0.57) | CA2CA1CA9CA12CA4 | |
| Valeric Acid SCHEMBL29009862 | 0.74 | AKR1B1 (0.56) | LMNAHSD17B10HTR7TSHR | |
| Valeric Acid SCHEMBL28272409 | 0.73 | AKR1B1 (0.61) | LMNAHSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114450294-A | Polypeptide with MMP2 inhibitory effect | 大正制药株式会社 | 2022-05-06 | — | — | CN | disclosed |